1. Stocks
    2. /
  2. BioNTech SE (NASDAQ: BNTX)
    3. /

BioNTech SE (NASDAQ: BNTX) Share Price and News

$88.77 $1.96 (2.3%) 26 March 2026 at 7:00:00 am AEDT

BioNTech SE Chart and Price Data

About BioNTech Se

Last updated 26-03-2026, 07:00:00am AEDT
Current Price $88.77
Change $1.96 (2.3%)
Close Price $88.77
Open Price $88.00
Bid $88.00
Ask $89.19
Day Range $87.76 - $89.17
Year Range $79.52 - $124.00
Volume 648,227
Average Volume 1,165,053
Market Cap $21,817,523,200.00
Earnings Per Share $-5.23

BioNTech SE (NASDAQ: BNTX)
Latest News

Ask a Fund Manager

4 healthcare share tips from a fundie with a health PhD

| Tony Yoo

Ask A Fund Manager: Platinum Asset Management's Dr Bianca Ogden picks 2 medical stocks still under the radar, plus 2…

Read more »

asx share associated with COVID vaccine represented by lab tech drawing down syringe
International Stock News

Pfizer to develop mRNA vaccines without BioNTech

| Cory Renauer

The pharmaceutical heavyweight thinks it won't need any more help to whip up new mRNA-based vaccines.

Read more »

coronavirus vaccine represented by gloved hand drawing down from syringe
International Stock News

Johnson & Johnson coronavirus vaccine wins FDA authorisation

| Eric Volkman

The big pharmaceutical company's jab has some important advantages.

Read more »

Vaccine vials sitting on top of a pile of US cash
International Stock News

The most popular coronavirus stock may lose half its value by 2023

| Sean Williams

This as-of-now unstoppable COVID-19 stock might be one of the worst investments going forward.

Read more »

vials of medication labelled with COVID-19 vaccine stickers
Share Market News

CSL (ASX:CSL) share price on watch after hints of 'far more robust' vaccine

| Bernd Struben

Australian global biotech giant CSL Limited didn't win the sprint for a coronavirus vaccine. But it may lead the marathon.

Read more »

woman waering face mask holding vial of covid-19 vaccine
International Stock News

Why Pfizer and BioNTech stocks popped Wednesday

| Joe Tenebruso

The healthcare leaders became the first to receive emergency authorization for their coronavirus vaccine.

Read more »

doctor holding covid-19 vaccine bottle
International Stock News

3 key advantages Moderna holds over Pfizer and AstraZeneca

| Keith Speights

They could add up to make Moderna a much bigger winner for investors than either of the two big pharma…

Read more »

Doctor holding small world globe in one hand and a Covid vaccine needle in the other
International Stock News

Why AstraZeneca's potential vaccine is more exciting than you think

| Jason Hawthorne

Investors are missing the big picture in the drugmaker's vaccine announcement.

Read more »

Cash piled up in the middle of a bear trap symbolising risky investments
International Stock News

Why Moderna Is Less Risky Than You Think

| Manali Bhade

Its coronavirus vaccine will likely be successful; its technology has huge potential; and the company has a healthy balance sheet.

Read more »

small figure representing ASX shares with cape and shield fighting coronavirus
Share Gainers

With the Moderna (NASDAQ:MRNA) share price blasting up, have the forward-looking markets got it right?

| Bernd Struben

The Moderna (NASDAQ: MRNA) share price is going gangbusters as the world awaits results of its COVID-19 vaccine trial. Let's…

Read more »

vials of medication labelled with COVID-19 vaccine stickers
International Stock News

Here's why Moderna's coronavirus vaccine could outsell Pfizer's

| Alex Carchidi

Moderna's candidate is cool with being kept at warmer temperatures.

Read more »

A health worker drug testing in a lab to find 'covid-19 vaccine' representing covid shares
International Stock News

New data shows higher efficacy rate for Pfizer and BioNTech coronavirus vaccine candidate

| Eric Volkman

The 2 companies plan to submit BNT162b2 for emergency use authorisation in the very near future.

Read more »

Profile

since

Note